Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Imaavy
Pharma
FDA endorses J&J’s Imaavy to treat rare anemia disorder
The FDA has signed off on a label expansion for Johnson & Johnson's Imaavy, approving it as a treatment for warm autoimmune hemolytic anemia.
Kevin Dunleavy
Aug 25, 2026 9:20am
J&J data set up Imaavy for expansion to treat anemic disorder
Jun 11, 2026 10:36am
Amgen nabs FDA nod for Uplizna in generalized myasthenia gravis
Dec 12, 2025 9:49am
Argenx lays out details on Vyvgart's seronegative gMG win
Oct 29, 2025 2:34pm
J&J's Imaavy comes up short in rheumatoid arthritis study
Aug 29, 2025 10:56am
J&J's Imaavy wins FDA green light in myasthenia gravis
Apr 30, 2025 10:51am
